Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
10/2008
10/23/2008WO2008126098A1 Extended release pharmaceutical formulation of propranolol hydrochloride
10/23/2008WO2008126076A2 Low-dose mometasone formulations
10/23/2008WO2008125940A2 Nanoparticles comprising non-crystalline drug
10/23/2008WO2008125843A1 Pharmaceutical compositions
10/23/2008WO2008125778A2 Rehydration composition for preparing a solute by reconstitution in water
10/23/2008WO2008125423A1 Non-ionizable hydrophobic galenical system
10/23/2008WO2008125388A1 Pharmaceutical compositions comprising irbesartan
10/23/2008WO2008125134A1 Process for the preparation of perindopril-tert-butylamine adsorbates
10/23/2008WO2008125035A1 Sweetener granula
10/23/2008WO2008124928A1 Freezable unit dosage delivery system and method of preparation
10/23/2008WO2008109230A3 Therapeutic composition with enhanced endothelium targeting
10/23/2008WO2008104720A3 Patch for cutaneous application
10/23/2008WO2008088456A3 Methods, compositions and devices for treating leasioned sites using bioabsorbable carriers
10/23/2008WO2008080809A3 Pharmaceutical composition containing psyllium and senna
10/23/2008WO2008079674A3 Processes for making cyclic lipid implants for intraocular use
10/23/2008WO2008076467A9 Intraoperative imaging methods
10/23/2008WO2008071966A3 Pharmaceutical composition of zolpidem
10/23/2008WO2008070495A3 Short term slow release drug delivery system
10/23/2008WO2008070291A3 Improved linkers for anchoring targeting ligands
10/23/2008WO2008067145A3 Self-assembling peptide amphiphiles
10/23/2008WO2008066507A3 Nanotube devices for targeted delivery of therapeutic molecules
10/23/2008WO2008059298A3 Pharmaceutical composition containing clopidogrel hydrogenesulphate of polymorph 1 form
10/23/2008WO2008058691A3 Powder formulation for inhalation
10/23/2008WO2008054659A3 An improved method of micro-encapsulation
10/23/2008WO2008052037A3 Packaging materials for formulations containing 2-pyrrolidone derivatives
10/23/2008WO2008048298A3 Polymer particles for delivery of macromolecules and methods of use
10/23/2008WO2008023277A3 Compositions containing coenzyme q-10 and dihydrolipoic acid
10/23/2008WO2008021800A3 Method for preventing crystallization
10/23/2008WO2008010788A3 Compositions and methods for making and using nanoemulsions
10/23/2008WO2008008592A3 Multi-particulate formulation having tramadol in immediate and controlled release form
10/23/2008WO2008005819A3 Ophthalmic formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
10/23/2008WO2008005276A3 Growth factor delivery system containing antimicrobial agents
10/23/2008WO2008002893A8 Anti-amyloid antibodies, compositions, methods and uses
10/23/2008WO2007140228A3 Nicotine-alternative compositions and methods of producing such compositions
10/23/2008WO2007133812A3 Improved carriers for delivery of nucleic acid agents to cells and tissues
10/23/2008WO2007125383A3 Topical drug delivery by iontophoresis
10/23/2008WO2007124489A3 Anticancer treatment with a combination of taxanes and 13-deoxyanthracyclines
10/23/2008WO2007112967A8 Process for the preparation of water-in-oil and oil-in-water nanoemulsions
10/23/2008WO2007106415A3 Triggered self-assembly conjugates and nanosystems
10/23/2008WO2007097922A3 Receptor-based blood detoxification system
10/23/2008WO2007054818A3 Foamable vehicle and pharmaceutical compositions thereof
10/23/2008WO2005115341A3 Microparticles for oral delivery
10/23/2008US20080263607 Downloading and Transfer of Audio or Video Data from Video Broadcasts
10/23/2008US20080262478 Device for Controlled Release of Chemical Molecules
10/23/2008US20080262284 Disposable products ; multilayer; interior and exterior layers forming reservoirs; heat activated adhesives; sealing; colorimetric analysis
10/23/2008US20080262210 Immunostimulating Agents
10/23/2008US20080262107 Pharmaceutical Compositions With Enhanced Performance
10/23/2008US20080262106 Direct Compressible Trehalose Solids
10/23/2008US20080262091 Analgesic/antinociceptive agents comprising 1-15,000mu g of capsaicin and other capsaicinoids in a vehicle; side effect reduction; neuropathic pain; neurotransmitter-dysregulation syndromes; incapacitation of C-fibers and/or A-delta fibers; denervate edges without eliciting an effect outside the edge
10/23/2008US20080262013 Oxymorphone controlled release formulations
10/23/2008US20080261919 Camptothecin-analog with a novel, "flipped" lactone-stable, E-ring and methods for making and using same
10/23/2008US20080261866 Compositions Comprising Glycosaminoglycan and Nonsteroidal Anti-Inflammatory Drug
10/23/2008US20080261303 Method and medicament for inhibiting the expression of a given gene
10/23/2008US20080261262 Lysis/Resealing Process and Device for Incorporating an Active Ingredient, in Particular Asparaginase or Inositol Hexaphosphate, in Erythrocytes
10/23/2008US20080260859 Dietary supplement to treat dry eye condition; fish oil triglycerides, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, zinc sulphate, vitamin E, vitamin C, vitamin B6, vitamin B12; solid, liquid, or gel; glycerol monostearate, lecithin, gelatin
10/23/2008US20080260852 Supercritical fluid extraction produced by in-line homogenization
10/23/2008US20080260851 Comprised of acrylic acid or acrylamide; well dispersed in water due to their size, and can contain, encapsulate, incorporate, extract and release molecules, such as active molecules, agents, or ingredients, including bioactive molecules
10/23/2008US20080260850 Delivery System For Bioactive Agents on the Basis of a Polymeric Drug Carrier Comprising an Amphiphilic Block Polymer and a Polylacticacid Derivative
10/23/2008US20080260849 Composition for transmucosal absorption
10/23/2008US20080260848 Rapid action and high absorbability of non-peptide/non-protein drugs; powder
10/23/2008US20080260847 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent
10/23/2008US20080260846 Has acceptable biodegradable polymer; polyglycolic acid, polylactic acid; Parkinson's Disease; injectable microspheres, injectable gels and implants; enhanced bioavailability
10/23/2008US20080260845 Multiple active drug resin conjugate
10/23/2008US20080260844 Solid, Oral, Microparticulate Dosage Form Which Has Been Designed To Prevent Misuse
10/23/2008US20080260843 transpulmonary composition
10/23/2008US20080260842 Permeation enhancing compositions for anticholinergic agents
10/23/2008US20080260840 glucagon-like peptide-1; osmotic drug delivery device and method
10/23/2008US20080260839 Stable, high porosity silicon microparticle aerosol carriers derived from semiconductor p+ wafers; resorbable and/or photoluminescent
10/23/2008US20080260838 Pulmonary delivery of GLP in combination with diketopiperazine that is stable both in vitro and in vivo; diabetes, cancers, and obesity
10/23/2008US20080260837 Comprising active drug component sparingly soluble to insoluble in water, water soluble low viscosity grade cellulose polymer with viscosity range of 3 to 50 mPa*s as a surfactant, suspending agent and water; storage stability, uniformity and well suited for both geriatric and pediatric administration
10/23/2008US20080260836 Films Comprising a Plurality of Polymers
10/23/2008US20080260835 Bioavailability; solid dispersion; dosage forms
10/23/2008US20080260834 Localized delivery of 1,25 D3 directly to target area using biodegradable polymeric matrices maximizes the efficacy of drug while minimizing systemic exposure and toxicity; inhibit tumor viability or proliferation
10/23/2008US20080260833 Drug loaded vesicles in hydrogel matrix; made of stimulus responsive polymer; poly(2-methyl-2-oxazoline)-b-polydimethylsiloxane-b-poly(2-methyl-2-oxazoline)
10/23/2008US20080260832 Sustained release intraocular implants and methods for preventing retinal dysfunction
10/23/2008US20080260831 useful as cell growth scaffolds; molded prior to implantation or administered to patient in an ungelled form prior to gelation where the composition gels in situ
10/23/2008US20080260830 suitable for regeneration, growth stimulation and differentiation of various cells, tissues and organs; growth/differentiation factors (GDFs); regeneration of connective tissue including tendon and/or ligament, periodontal or dental tissue including dental implants, neural tissue and sensory tissues
10/23/2008US20080260829 Bone morphogenic proteins (bmp); cell adhesion modulating agent; peptidomimetics of cyclic peptides comprising classical cadherin cell adhesion recognition (CAR) sequences; modulate cell adhesion and improve drug delivery
10/23/2008US20080260828 Stable solid dispersion of a derivative of vinca alkaloid and process for manufacturing it
10/23/2008US20080260827 Continuous dosing schedule of one, two, or three consecutive days per month for osteoporosis, other bone disorders; patient compliance
10/23/2008US20080260826 Compressed tablet formulation containing active ingredient 4'-azidocytidine-2', 3', 5'-tri-isobutyrate hydrochloride and ethylene glycol-propylene glycol block copolymer; gel inhibition during formulation; enhanced gastrointestinal dissolution and absorption; hepatitis C virus
10/23/2008US20080260825 Methods and Compositions for Reduction of Side Effects of Therapeutic Treatments
10/23/2008US20080260824 Bioadhesive Rate-Controlled Oral Dosage Formulations
10/23/2008US20080260823 Ease of administration for patients who have difficulty swallowing; side effect reduction; drooling prevention; neurological disorders
10/23/2008US20080260822 SYNTHESIS OF HUMAN SECRETORY IgA AND IgM AND THE FORMATION OF A MEDICAMENT THEREFROM
10/23/2008US20080260821 Berry Preparations and Extracts
10/23/2008US20080260820 Providing effective gastrointestinal tract drug delivery; therapeutic protein having primary amino acid sequence modification
10/23/2008US20080260819 Sustained release compositions of drugs
10/23/2008US20080260818 Controlled Absorption of Statins in the Intestine
10/23/2008US20080260817 Such as celecoxib with 2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)benzoic acid; cyclooxygenase 2 (Cox 2), leukotriene B4 (Ltb4); arthritis
10/23/2008US20080260816 Particulate Lipid Pharmaceutical Composition
10/23/2008US20080260815 Multiparticulates
10/23/2008US20080260814 Minimizing plant contamination; high throughput; fracture and streaking prevention; heat resistant moldings; including devolatilization step
10/23/2008US20080260813 Pharmaceutical composition of topiramate
10/23/2008US20080260812 Therapeutic Medicine Containing Monoclonal Antibody Against Folate Receptor Beta (Fr-Beta)
10/23/2008US20080260811 patches has pressure-sensitive adhesive matrix containing a polyisobutylene, free of permeation enhancer, for drug deliverying sufentanil through the skin to provide an analgesic effect, pain management; sustained release, side effect reduction; consistent concentration in blood
10/23/2008US20080260809 Polyether combined with hydrophilic cellulosic material; demonstrates non-self-aggregating, uniform heterogeneity; mucosally adhesive water soluble product containing analgesic opiate; preventing air pocket formation during production
10/23/2008US20080260808 Providing prolonged cosmetic and/or therapeutic treatment; thin shaped flexible sheet with adhesive and active ingredients; low cost, easy to use
10/23/2008US20080260807 Water-Soluble Films Comprising Nicotine
10/23/2008US20080260806 Towelette containing astringent, humectant and botanical extract; cleaning, deodorizing; safe for sensitive skin
1 ... 1163 1164 1165 1166 1167 1168 1169 1170 1171 1172 1173 1174 1175 1176 1177 1178 1179 1180 1181 1182 1183 ... 2991